UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014151
Receipt number R000015849
Scientific Title Evaluation of intestinal permeability in patients with chronic liver disease
Date of disclosure of the study information 2014/06/30
Last modified on 2022/12/09 12:20:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of intestinal permeability in patients with chronic liver disease

Acronym

Intestinal permeability in patients with chronic liver disease

Scientific Title

Evaluation of intestinal permeability in patients with chronic liver disease

Scientific Title:Acronym

Intestinal permeability in patients with chronic liver disease

Region

Japan


Condition

Condition

chronic liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of intestinal permeability in patients with chronic liver disease

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Influence of intestinal permeabilitiy on the progression of chronic liver disease

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

patients with chronic liver disease

Key exclusion criteria

platelet counts:50,000/(mm)3 or less
or
PT INR: 2 or more

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Masatoshi
Middle name
Last name Ishigami

Organization

Nagoya University Graduate School of Medicine

Division name

Gastroentelorogy and Hepatology

Zip code

466-8550

Address

Nagoya city Showa-ku Turuma-sho 65

TEL

0527442169

Email

y-ishizu@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Yoji
Middle name
Last name ishizu

Organization

Nagoya University Graduate School of Medicine

Division name

Gastroentelorogy and Hepatology

Zip code

466-8550

Address

Nagoya city Showa-ku Turuma-sho 65

TEL

0527442169

Homepage URL


Email

y-ishizu@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine, Department of Gastroentelorogy and Hepatology

Institute

Department

Personal name



Funding Source

Organization

Nagoya University Graduate School of Medicine, Department of Gastroentelorogy and Hepatology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee

Address

Nagoya city Showa-ku Turuma-sho 65

Tel

0527442169

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 30 Day


Related information

URL releasing protocol

no

Publication of results

Unpublished


Result

URL related to results and publications

no

Number of participants that the trial has enrolled

20

Results

Atrophy of the small intestinal mucosa was observed in patients with chronic liver disease, but the relationship between pathology and mucosal morphology could not be shown.

Results date posted

2022 Year 12 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

liver cirrhosis

Participant flow

Only patients with consent were included in the study.

Adverse events

none

Outcome measures

Relationship between the morphology of the small intestinal mucosa and liver function

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 06 Month 10 Day

Date of IRB

2014 Year 06 Month 10 Day

Anticipated trial start date

2014 Year 06 Month 10 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2017 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 06 Month 03 Day

Last modified on

2022 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015849


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name